The survival benefit of periprocedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty is determined by use of these drugs before admission
Publication
, Conference
Halkin, A; Nikolsky, E; Aymong, E; Mehran, R; Tcheng, JE; Cox, DA; Stuckey, T; Lansky, AJ; Stone, GW
Published in: AMERICAN JOURNAL OF CARDIOLOGY
September 15, 2003
Duke Scholars
Published In
AMERICAN JOURNAL OF CARDIOLOGY
ISSN
0002-9149
Publication Date
September 15, 2003
Volume
92
Issue
6A
Start / End Page
228L / 228L
Location
WASHINGTON, D.C.
Publisher
EXCERPTA MEDICA INC
Conference Name
15th Annual Transcatheter Cardiovascular Therapeutics Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Halkin, A., Nikolsky, E., Aymong, E., Mehran, R., Tcheng, J. E., Cox, D. A., … Stone, G. W. (2003). The survival benefit of periprocedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty is determined by use of these drugs before admission. In AMERICAN JOURNAL OF CARDIOLOGY (Vol. 92, pp. 228L-228L). WASHINGTON, D.C.: EXCERPTA MEDICA INC.
Halkin, A., E. Nikolsky, E. Aymong, R. Mehran, J. E. Tcheng, D. A. Cox, T. Stuckey, A. J. Lansky, and G. W. Stone. “The survival benefit of periprocedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty is determined by use of these drugs before admission.” In AMERICAN JOURNAL OF CARDIOLOGY, 92:228L-228L. EXCERPTA MEDICA INC, 2003.
Halkin A, Nikolsky E, Aymong E, Mehran R, Tcheng JE, Cox DA, et al. The survival benefit of periprocedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty is determined by use of these drugs before admission. In: AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 2003. p. 228L-228L.
Halkin, A., et al. “The survival benefit of periprocedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty is determined by use of these drugs before admission.” AMERICAN JOURNAL OF CARDIOLOGY, vol. 92, no. 6A, EXCERPTA MEDICA INC, 2003, pp. 228L-228L.
Halkin A, Nikolsky E, Aymong E, Mehran R, Tcheng JE, Cox DA, Stuckey T, Lansky AJ, Stone GW. The survival benefit of periprocedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty is determined by use of these drugs before admission. AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 2003. p. 228L-228L.
Published In
AMERICAN JOURNAL OF CARDIOLOGY
ISSN
0002-9149
Publication Date
September 15, 2003
Volume
92
Issue
6A
Start / End Page
228L / 228L
Location
WASHINGTON, D.C.
Publisher
EXCERPTA MEDICA INC
Conference Name
15th Annual Transcatheter Cardiovascular Therapeutics Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology